Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Transitional cell cancer of the renal pelvis and ureter
ADR ID BADD_A11078
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.08      Renal and urinary tract neoplasms malignant and unspecified
16.08.05      Renal pelvis and ureter neoplasms malignant
16.08.05.003      Transitional cell cancer of the renal pelvis and ureter
20      Renal and urinary disorders
20.08      Genitourinary tract disorders NEC
20.08.01      Genital and urinary tract disorders NEC
20.08.01.015      Transitional cell cancer of the renal pelvis and ureter
Description Not Available
MedDRA Code 10044407
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Malignant neoplasm of renal pelvis and ureter NOS transitional cell | Renal pelvis and ureter transitional cell cancer NOS | Renal pelvis and ureteral cancer transitional cell NOS | Renal pelvis and ureteric cancer NOS transitional cell | Renal pelvis and ureteric cancer transitional cell NOS | Transitional cell cancer of the renal pelvis and ureter | Transitional cell cancer of the renal pelvis and ureter NOS | Transitional cell carcinoma ureter | Ureter transitional cell cancer | Urothelial carcinoma ureter | Urothelial cancer of renal pelvis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02331Valsartan0.000053%
The 1th Page    1    Total 1 Pages